30-Day FRN - Update to Data Sharing Language in SSA

Federal Register / Vol. 89, No. 127 / Tuesday, July 2, 2024 / Notices
Statutory Authority: Ms. L. v. U.S.
Immigration and Customs Enforcement
(2023) Settlement Agreement (Section
IV.B.), available at: https://
www.justice.gov/opa/file/1319516/
dl?inline.
Elizabeth Leo,
Policy Branch Chief, Office of Grants Policy,
Office of Administration.
[FR Doc. 2024–14591 Filed 6–28–24; 11:15 am]
BILLING CODE 4184–90–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Submission for Office of Management
and Budget (OMB) Review; Revisions
to Two Information Collections:
Medical Assessment Form and Dental
Assessment Form (OMB #0970–0466)
and Mental Health Assessment Form
and Public Health Investigation Forms,
Tuberculosis and Non-Tuberculosis
Illness (OMB #0970–0509)
Office of Refugee Resettlement,
Administration for Children and
Families, U.S. Department of Health and
Human Services.
ACTION: Request for public comments.
AGENCY:

The Administration for
Children and Families (ACF) is
proposing a change of the described
potential uses of data for two
information collections: Medical
Assessment Form and Dental
Assessment Form (OMB #: 0970–0466)
and Mental Health Assessment Form
and Public Health Investigation Forms,
Tuberculosis and Non-Tuberculosis
Illness (OMB: #0970–0509).
DATES: Comments due August 1, 2024.
OMB has agreed to make a decision
about the updates to these collections of
information following a public comment
period of 30 days. Therefore, a comment
is best assured of having its full effect
if ACF receives it within 30 days of
publication.
SUMMARY:

You can obtain copies of the
proposed changes and submit comments
by emailing [email protected].
Identify all requests by the title of the
information collection.
SUPPLEMENTARY INFORMATION:
Description: The following two ORR
information collections capture health
data on children in ORR care:
• Medical Assessment Form and Dental
Assessment Form
• Mental Health Assessment Form and
Public Health Investigation Form:

lotter on DSK11XQN23PROD with NOTICES1

ADDRESSES:

VerDate Sep<11>2014

17:34 Jul 01, 2024

Jkt 262001

Active TB, and Public Health
Investigation Form: Non-TB Illness
The current description of purpose
and use of the data collected states that
confidential and sensitive health
information will only be shared with
external stakeholders (including other
Federal agencies) for public health
purposes (e.g., contact investigations to
identify children exposed to a
reportable infectious disease). However,
ORR has identified a need to share the
health data of specific unaccompanied
children with the Department of
Homeland Security (DHS) which falls
outside of the stated limitations. The
need to communicate with DHS occurs
when a newly referred child arrives at
an ORR facility ill or requires emergent/
urgent healthcare services shortly after
placement and ORR was not notified in
advance. For DHS to investigate the
event, ORR must share confidential and
sensitive health information including
the child’s alien number, name, signs/
symptoms, diagnoses, and date of
diagnosis. The goal of this data sharing
effort is to identify areas of potential
improvement in delivery of healthcare
services and continuity of care for
children transferred from DHS to Health
and Human Services custody.
Respondents: Healthcare providers
(pediatricians, medical specialists, and
dentists), mental health professionals
(psychiatrists, psychiatric nurse
practitioners or physician’s assistants,
licensed psychologist or any other
community based licensed mental
health provider (e.g., social worker),
care provider program staff.
Annual Burden Estimates: No
changes. For current burden estimates,
see information below:
• https://www.reginfo.gov/public/do/
PRAViewICR?ref_nbr=202312-0970002
• https://www.reginfo.gov/public/do/
PRAViewICR?ref_nbr=202312-0970003
Authority: 6 U.S.C. 279: Exhibit 1,
part A.2 of the Flores Settlement
Agreement (Jenny Lisette Flores, et al.,
v. Janet Reno, Attorney General of the
United States, et al., Case No. CV 85–
4544–RJK [C.D. Cal. 1996]).
Mary C. Jones,
ACF/OPRE Certifying Officer.
[FR Doc. 2024–14556 Filed 7–1–24; 8:45 am]
BILLING CODE 4184–45–P

PO 00000

Frm 00068

Fmt 4703

Sfmt 4703

54829

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket Nos. FDA–2023–E–3130 and FDA–
2023–E–3135]

Determination of Regulatory Review
Period for Purposes of Patent
Extension; XENPOZYME
AGENCY:

Food and Drug Administration,

HHS.
ACTION:

Notice.

The Food and Drug
Administration (FDA or the Agency) has
determined the regulatory review period
for XENPOZYME and is publishing this
notice of that determination as required
by law. FDA has made the
determination because of the
submission of an application to the
Director of the U.S. Patent and
Trademark Office (USPTO), Department
of Commerce, for the extension of a
patent which claims that human
biological product.
DATES: Anyone with knowledge that any
of the dates as published (see
SUPPLEMENTARY INFORMATION) are
incorrect may submit either electronic
or written comments and ask for a
redetermination by September 3, 2024.
Furthermore, any interested person may
petition FDA for a determination
regarding whether the applicant for
extension acted with due diligence
during the regulatory review period by
December 30, 2024. See ‘‘Petitions’’ in
the SUPPLEMENTARY INFORMATION section
for more information.
ADDRESSES: You may submit comments
as follows. Please note that late,
untimely filed comments will not be
considered. The https://
www.regulations.gov electronic filing
system will accept comments until
11:59 p.m. Eastern Time at the end of
September 3, 2024. Comments received
by mail/hand delivery/courier (for
written/paper submissions) will be
considered timely if they are received
on or before that date.
SUMMARY:

Electronic Submissions
Submit electronic comments in the
following way:
• Federal eRulemaking Portal:
https://www.regulations.gov. Follow the
instructions for submitting comments.
Comments submitted electronically,
including attachments, to https://
www.regulations.gov will be posted to
the docket unchanged. Because your
comment will be made public, you are
solely responsible for ensuring that your
comment does not include any
confidential information that you or a

E:\FR\FM\02JYN1.SGM

02JYN1